The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, ...
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said. "Too ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback